Cargando…

The Urgent Threat of Clostridioides difficile Infection: A Glimpse of the Drugs of the Future, with Related Patents and Prospects

Clostridioides difficile infection (CDI) is an urgent threat and unmet medical need. The current treatments for CDI are not enough to fight the burden of CDI and recurrent CDI (r-CDI). This review aims to highlight the future drugs for CDI and their related patented applications. The non-patent lite...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alshrari, Ahmed S., Hudu, Shuaibu Abdullahi, Elmigdadi, Fayig, Imran, Mohd.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953237/ https://www.ncbi.nlm.nih.gov/pubmed/36830964 http://dx.doi.org/10.3390/biomedicines11020426

Ejemplares similares

VP37 Protein Inhibitors for Mpox Treatment: Highlights on Recent Advances, Patent Literature, and Future Directions
por: Hudu, Shuaibu A., et al.
Publicado: (2023)

Hepatitis B Therapeutic Vaccine: A Patent Review
por: Hudu, Shuaibu Abdullahi, et al.
Publicado: (2022)

Innovations and development of Covid-19 vaccines: A patent review
por: Alshrari, Ahmed S., et al.
Publicado: (2022)

Trofinetide for Rett Syndrome: Highlights on the Development and Related Inventions of the First USFDA-Approved Treatment for Rare Pediatric Unmet Medical Need
por: Hudu, Shuaibu A., et al.
Publicado: (2023)

Isolated hepatitis B core antibody positive among vaccinated cohort in Malaysia
por: Hudu, Shuaibu Abdullahi, et al.
Publicado: (2013)

Antibody and immune memory persistence post infant hepatitis B vaccination
por: Hudu, Shuaibu A, et al.
Publicado: (2013)

Identification of a 1,2,4-Oxadiazole with Potent and Specific Activity against Clostridioides difficile, the Causative Bacterium of C. difficile Infection, an Urgent Public Health Threat
por: Barbachyn, Michael R.
Publicado: (2023)

Trends in the development of remdesivir based inventions against COVID-19 and other disorders: A patent review
por: Imran, Mohd., et al.
Publicado: (2021)

Challenges and future solutions for detection of Clostridioides difficile in adults
por: Biswas, Rima, et al.
Publicado: (2023)

A glimpse at the future
por: Böhm, György Miklós
Publicado: (2016)

Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021)

Development of Therapeutic and Prophylactic Zinc Compositions for Use against COVID-19: A Glimpse of the Trends, Inventions, and Patents
por: Imran, Mohd, et al.
Publicado: (2022)

Iron Regulation in Clostridioides difficile
por: Berges, Mareike, et al.
Publicado: (2018)

Extraintestinal Clostridioides difficile infection
por: Hai, Zhao, et al.
Publicado: (2020)

Pathogenicity and virulence of Clostridioides difficile
por: Buddle, Jessica E., et al.
Publicado: (2023)

Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19
por: Imran, Mohd., et al.
Publicado: (2021)

Isolation of Janthinobacterium lividum from early onset neonatal sepsis patients in Malaysia
por: Shinkafi, Sa'adatu Haruna, et al.
Publicado: (2019)

Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection
por: Ahn, Seung Woo, et al.
Publicado: (2021)

In vitro models to study Clostridioides difficile infection: current systems and future advances
por: Ewin, Duncan, et al.
Publicado: (2023)

STED nanoscopy: a glimpse into the future
por: Bianchini, Paolo, et al.
Publicado: (2015)

Treatments for HBV: A Glimpse into the Future
por: Bartoli, Alessandra, et al.
Publicado: (2021)

Non-proctology: A Glimpse into the Future
por: Lynch, Jerome Morley
Publicado: (1917)

Metabolism the Difficile Way: The Key to the Success of the Pathogen Clostridioides difficile
por: Neumann-Schaal, Meina, et al.
Publicado: (2019)

Clostridioides difficile therapeutics: guidelines and beyond
por: Orenstein, Robert, et al.
Publicado: (2019)

Impact of ribotype on Clostridioides difficile diagnostics
por: Rizzardi, Kristina, et al.
Publicado: (2019)

Clostridioides (Clostridium) difficile Pacemaker Infection
por: Berkefeld, Anna, et al.
Publicado: (2020)

Opportunities for Nanomedicine in Clostridioides difficile Infection
por: Wang, Pei-Wen, et al.
Publicado: (2021)

Introduction to the Special Issue on Clostridioides difficile
por: Granata, Guido, et al.
Publicado: (2021)

Epidemiology of Clostridioides difficile in South Africa
por: de Jager, Pieter, et al.
Publicado: (2021)

The repertoire of ABC proteins in Clostridioides difficile
por: Pipatthana, Methinee, et al.
Publicado: (2021)

An Update on Clostridioides difficile Binary Toxin
por: Martínez-Meléndez, Adrián, et al.
Publicado: (2022)

Clostridioides difficile: A diagnostic intervention
por: Alsoubani, Majd, et al.
Publicado: (2022)

Phage therapy for Clostridioides difficile infection
por: Fujimoto, Kosuke, et al.
Publicado: (2022)

Clostridioides difficile, a New “Superbug”
por: Markovska, Rumyana, et al.
Publicado: (2023)

Editorial: Microbial interactions of Clostridioides difficile
por: Goh, Shan, et al.
Publicado: (2023)

High levels of toxigenic Clostridioides difficile contamination of hospital environments: a hidden threat in hospital-acquired infections in Kenya
por: Odoyo, Erick, et al.
Publicado: (2020)

Prospective Study on Incidence, Risk Factors and Outcome of Recurrent Clostridioides difficile Infections
por: Granata, Guido, et al.
Publicado: (2021)

A prospective, observational study of fidaxomicin use for Clostridioides difficile infection in France
por: Guery, Benoit, et al.
Publicado: (2021)

Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective
por: Raeisi, Hamideh, et al.
Publicado: (2022)

Diversity, Dynamics and Therapeutic Application of Clostridioides difficile Bacteriophages
por: Nale, Janet Y., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7hdetbvmt85udh4221nesbmou9